MoonLake Immunotherapeutics - Sonelokimab在Vela试验中所有主要及关键次要终点均显示显著改善
MoonLake Immunotherapeutics - Sonelokimab在Vela试验中所有主要及关键次要终点均显示显著改善
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.